Can we manage the melanocytic lesions with peripheral globules according to the grade of dysplasia?

Documenti analoghi

• Tissue Eosinophil Counts: A Promising Marker for Optimizing Omalizumab Treatment in Bullous Pemphigoid
  di: Gülfem Akin, et al.
  Pubblicazione: (2025)
• Australasian hidradenitis suppurativa management guidelines
  di: John Frew, et al.
  Pubblicazione: (2024)
• Interleukin‐17 inhibitors for the management of severe rosacea
  di: Sera Sarsam, et al.
  Pubblicazione: (2024)
• Prognostic factors in Kaposi sarcoma, single centre experience
  di: Ezgi Değerli, et al.
  Pubblicazione: (2024)
• Experience of dermatologic biologic therapy use and associated opportunistic infection management in Australia's tropical north
  di: Lucinda Adams, et al.
  Pubblicazione: (2024)